RIGL Stock Summary and Trading Ideas (Rigel Pharmaceuticals | NASDAQ:RIGL)

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

What symbol and exchange does Rigel Pharmaceuticals shares trade?

Rigel Pharmaceuticals trades on the NASDAQ stock market under the symbol RIGL.

What is Rigel Pharmaceuticals stock price doing today?

As of January 16, 2026, RIGL stock price declined to $37.48 with 263,178 million shares trading.

What is Rigel Pharmaceuticals's Beta?

RIGL has a beta of 1.17, meaning it tends to be more sensitive to market movements. RIGL has a correlation of 0.08 to the broad based SPY ETF.

How much is Rigel Pharmaceuticals worth?

RIGL has a market cap of $672.29 million. This is considered a Small Cap stock.

How much money does Rigel Pharmaceuticals make?

Last quarter Rigel Pharmaceuticals reported $69 million in Revenue and $1.46 earnings per share. This beat revenue expectation by $8 million and exceeded earnings estimates by $.61.

What is the highest and lowest price Rigel Pharmaceuticals traded in the last 3 year period?

In the last 3 years, RIGL traded as high as $52.24 and as low as $7.12.

What are the top ETFs holding Rigel Pharmaceuticals?

The top ETF exchange traded funds that RIGL belongs to (by Net Assets): XBI, VTI, IWM, AVUV, VXF.

Is Rigel Pharmaceuticals (RIGL) a good investment?

RIGL has outperformed the market in the last year with a return of +116.0%, while the SPY ETF gained +18.1%. In the last 3 month period, RIGL beat the market returning +33.3%, while SPY returned +5.0%. However, in the most recent 2 weeks RIGL has underperformed the stock market by returning -10.4%, while SPY returned +1.2%.

What are the support and resistance levels for Rigel Pharmaceuticals (RIGL)?

RIGL support price is $36.21 and resistance is $39.35 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RIGL shares will trade within this expected range on the day.